首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
【24h】

Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.

机译:作为新型抗肿瘤药物的3-取代的1,4-二氢-4-氧代-1-(2-噻唑基)-1,8-萘啶的合成及其构效关系。

获取原文
获取原文并翻译 | 示例
       

摘要

In order to obtain clinically useful antitumor agent, we have designed and synthesized various 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines, and evaluated their cytotoxic activity. The series of novel 3-substituted derivatives synthesized in this study showed good antitumor activity against murine P388 leukemia. Particularly, the 3-formyl 1,8-naphthyridine displayed an antitumor activity equal to that of the 3-carboxy 1,8-naphthyridine against murine and human tumor cell lines as well as in vivo test for mouse leukemia. These results demonstrate that the carboxy group at the C-3 position of 1,8-naphthyridine ring is not essential for antitumor activity. In addition, the trend of cytotoxic activity for the 3-substituted 1,8-naphthyridines was different from that of antibacterial activity.
机译:为了获得临床上有用的抗肿瘤剂,我们设计并合成了各种3取代的1,4-二氢-4-氧代-1-(2-噻唑基)-1,8-萘啶,并评估了它们的细胞毒活性。在这项研究中合成的一系列新型3取代衍生物对小鼠P388白血病表现出良好的抗肿瘤活性。特别地,3-甲酰基1,8-萘啶具有与3-羧基1,8-萘啶相同的抗鼠和人肿瘤细胞系的抗肿瘤活性,以及​​对小鼠白血病的体内测试。这些结果证明1,8-萘啶环的C-3位的羧基对于抗肿瘤活性不是必需的。另外,对3-取代的1,8-萘啶的细胞毒性活性的趋势与抗菌活性的趋势不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号